« BackInternational Journal of Drug Policy
Article in Press

HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998–2007

  • Afarin Rahimi-Movaghar

      Affiliations

    • Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Imam Khomeini Hospital, Keshavarz Blvd., Postal code: 14197-33141, Tehran, Iran
  • ,
  • Masoumeh Amin-Esmaeili

      Affiliations

    • Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Imam Khomeini Hospital, Keshavarz Blvd., Postal code: 14197-33141, Tehran, Iran
    • Corresponding Author InformationCorresponding author at: Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Iran. Tel.: +98 21 66918899; fax: +98 21 66947984.
  • ,
  • Ali-akbar Haghdoost

      Affiliations

    • Research Center for Modeling in Health, Hygiene School, Kerman University of Medical Sciences, Jomhoori Islami Blvd, Shafa cross-road, P.O. Box: 76175-531, Kerman, Iran
  • ,
  • Behnam Sadeghirad

      Affiliations

    • Kerman Neuroscience Research Center (KNRC), Kerman University of Medical Sciences, Jomhoori Islami Blvd, Shafa cross-road, P.O. Box: 76175-113, Kerman, Iran
  • ,
  • Minoo Mohraz

      Affiliations

    • Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Imam Khomeini Hospital, Keshavarz Blvd., Postal code: 14197-33141, Tehran, Iran

Received 18 May 2011; received in revised form 25 July 2011; accepted 6 September 2011. published online 17 October 2011.
Corrected Proof

Abstract 

Background and objectives

Iran is a country with low HIV prevalence in the general population and concentrated prevalence amongst injecting drug users (IDUs). Various studies have been carried out on HIV prevalence amongst IDUs in Iran and diverse results have been reported. This systematic review intended to find and collect all relevant studies, assess the quality of data and provide estimations on the national prevalence over time.

Methods

A broad search strategy was used, including searching international and local databases, research reports, and extensive personal contacts. All studies of IDUs conducted between 1998 and 2007 including clear description of method and HIV testing and confirmative western blot test were entered and qualitatively assessed. HIV prevalence rates were pooled for gender and stratified into several categories.

Results

Twenty-two studies involving 3916 IDUs were included. Half of the studies had been conducted in Tehran. Ten studies were conducted in prisons, seven in treatment centres and five in the Drop-in-centres or communities. After 2005 the pooled HIV prevalence was 18.4% [95% Confidence Interval (CI) 16.7–20.2] significantly higher than the prevalence rate before 2005 [8.7% (95% CI 7.5–10].

Conclusion

HIV prevalence amongst IDUs has increased over time and has the potential to increase exponentially. Scaling up harm reduction measures, increasing their availability and coverage, and improving the quality of services is highly recommended in order to prevent a future catastrophic epidemic.

Keywords: Injecting drug use, HIV/AIDS, Prevalence, Systematic review, Harm reduction, Tehran, Iran

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(11)00164-2

doi:10.1016/j.drugpo.2011.09.002

« BackInternational Journal of Drug Policy